You are here: Industry Insights > Market News > Japan Health Ministry finds new coronavirus variant

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

3-Bromo-4-fluorobenzaldehyde

5-Methyl-1,3,4-oxadiazol2(3H)-one

4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride

4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine

3-Pyridinecarboxaldehyde

Ethyl 3 Fluorobenzoate

Japan Health Ministry finds new coronavirus variant

expresspharmaJanuary 12, 2021

Tag: coronavirus , variant , virus , Japan

Favorites

The Health Ministry of Japan has found a COVID-19 variant in people arriving from Brazil that’s different from the ones in Britain and South Africa.

The variant was identified in airport tests on a man in his 40s, a woman in her 30s and two teens, the ministry said.

Japan is working with other nations, the WHO and other medical experts to analyse the new version of the virus. It is not clear whether the current vaccines will be effective against the new variant.

About 30 cases of variants from Britain and South Africa have earlier been reported in Japan. Experts are worried the variants appear to spread faster.

Previous:Dr Reddy’s Laboratories launches Febuxostat Tablets in US

Next:JB Chemicals gets ANDA approval from US FDA for Loratadine Tablets

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

BioPharmaSpec, the leading global Contract Research Organization (CRO) for Discovery and Preclinical Characterization of Biopharmaceuticals, has officially announced three new European facilities.

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Japan Health Ministry finds new coronavirus variant | Pharmasources.com

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may like
More>>

3ml5ml nucleic acid detection bottle reagent bottle virus sampling tube plastic extraction tube drop

Measles virus antibody test strip

Entecavir 99%min Pharmaceutical Nucleoside Antivirus products made in china

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine

Recombinant Human Brain-Derived Neurotrophic Factor, variant 5

Virus Related Peptides

Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)

double virus inactivation Human Immunoglobulin (pH4) for Intravenous Injection

HEPA+ANTI-BACTERIAL/ ANTI-VIRUS FILTER

Desiccants use Japanese papaer

Japan Health Ministry finds new coronavirus variant

Related News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may likeMore>>

You may like
More>>